
- Mount Sinai Doctors
Jonathan Himmelfarb, MD
Nephrology
About Me
Jonathan Himmelfarb, MD, FASN, FAIMBE, FRCP (he/him) is a Professor of Medicine and the inaugural Co-Director of the Center for Kidney Disease Innovation (CKDi) in the Department of Medicine at Icahn School of Medicine of Mount Sinai. The CKDi is a multidisciplinary translational research center focused on advancing innovative treatments for kidney diseases through discovery science, patient engagement, and clinical trials.
Prior to joining the Icahn School of Medicine of Mount Sinai in 2024, Dr. Himmelfarb was the founding director of the Kidney Research Institute at the University of Washington from 2008 – 2022. At the University of Washington, he also co-founded the Center for Dialysis Innovation. He is well-known for his contributions to nephrology and kidney disease research innovation, including his work on the development of a portable, wearable artificial kidney, designed to give people more freedom and flexibility when compared to traditional dialysis. Dr. Himmelfarb has been an NIH-funded investigator for over 30 years and is currently leading research on kidney-on-a-chip systems for acute kidney injury and chronic kidney disease, as well as serving as the Steering Committee chair for the Kidney Precision Medicine Project (KPMP), and principal investigator for the KPMP Central Hub and Kidney Mapping Atlas Project.
Dr. Himmelfarb has authored over 400 publications with an H-index over 100 and 50,000+ citations. He is the first and only North American managing editor of the Oxford Textbook of Clinical Nephrology (4th edition) and was recently invited to join the editorial team for the 5th edition.
Dr. Himmelfarb is a prominent leader in nephrology, with significant roles in a variety of national and international organizations. He has been a member of the American Board of Internal Medicine Subspecialty Board on Nephrology, a Councilor of the American Society of Nephrology (ASN) and was President of the ASN in 2014-2015. He has served on expert panels for the U.S. Food and Drug Administration, Veterans Health Administration, Centers for Medicare & Medicaid Services and other organizations. Dr. Himmelfarb has served on numerous editorial boards including the Journal of the American Society of Nephrology (JASN), Clinical Journal of the American Society of Nephrology (CJASN), Kidney International, BMC Medicine, Nature reviews Nephrology, the Faculty of 1000 in Medicine, and the Faculty of 1000 in Research. In 2015, he was inducted into the National Academy of Medicine, which is part of the National Academies of Science, Engineering, and Medicine (NASEM). In 2021, he was honored with the Belding H. Scribner Lifetime Achievement Award from ASN for his groundbreaking contributions to the field. He also received the U.S. President’s Volunteer Service Award Gold Medal in 2022.
Dr. Himmelfarb earned his medical degree from George Washington University Medical School. He completed his residency at Maine Medical Center and a nephrology fellowship at Brigham Women’s Hospital and Maine Medical Center.
Language
English
Position
PROFESSOR | Medicine, Nephrology
Hospital Affiliations
- Mount Sinai Queens
- The Mount Sinai Hospital
Education
MD, George Washington University School of Medicine
Internship, Internal Medicine
Maine Medical Center
Residency, Internal Medicine
Maine Medical Center
Fellowship, Nephrology
Maine Medical Center
Fellowship, Nephrology
Brigham and Women's Hospital
Certifications
American Board of Internal Medicine
Insurance Information
Physicians who provide services at hospitals and facilities in the Mount Sinai Health System might not participate in the same health plans as those Mount Sinai hospitals and facilities (even if the physicians are employed or contracted by those hospitals or facilities).
Information regarding insurance participation and billing by this physician may be found on this page, and can also be obtained by contacting this provider directly. Because physicians insurance participation can change, the insurance information on this page may not always be up-to-date. Please contact this physician directly to obtain the most up-to-date insurance information.
Insurance and health plan networks that the various Mount Sinai Health System hospitals and facilities participate in can be found on the Mount Sinai Health System website.
Publications
Selected Publications
- Synthetic vascular graft that heals and regenerates. Le Zhen, Elina Quiroga, Sharon A. Creason, Ningjing Chen, Tanmay R. Sapre, Jessica M. Snyder, Sarah L. Lindhartsen, Brendy S. Fountaine, Michael C. Barbour, Syed Faisal, Alberto Aliseda, Brian W. Johnson, Jonathan Himmelfarb, Buddy D. Ratner. Biomaterials
- The Discrepancy Between Estimated GFR Cystatin C and Estimated GFR Creatinine at 3 Months After Hospitalization and Long-Term Adverse Outcomes. Yumeng Wen, Nityasree Srialluri, Danielle Farrington, Heather Thiessen-Philbrook, Steven Menez, Dennis G. Moledina, Steven G. Coca, T. Alp Ikizler, Eddie Siew, Alan Go, Chi yuan Hsu, Jonathan Himmelfarb, Vernon Chinchilli, James Kaufman, Paul L. Kimmel, Amit X. Garg, Morgan E. Grams, Chirag R. Parikh. Kidney International Reports
- A Pilot Trial of Nicotinamide Riboside and Coenzyme Q10 on Inflammation and Oxidative Stress in CKD. Armin Ahmadi, Ana P. Valencia, Gwénaëlle Begue, Jennifer E. Norman, Sili Fan, Blythe P. Durbin-Johnson, Bradley N. Jenner, Matthew D. Campbell, Gustavo Reyes, Pankaj Kapahi, Jonathan Himmelfarb, Ian H. de Boer, David J. Marcinek, Bryan R. Kestenbaum, Jorge L. Gamboa, Baback Roshanravan. Clinical Journal of the American Society of Nephrology
Industry Relationships
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device, biotechnology companies, and other outside entities to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their outside financial relationships.
Below are financial relationships with industry reported by Dr. Himmelfarb during 2024 and/or 2025. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.
Consulting or Other Professional Services Examples include, but are not limited to, committee participation, data safety monitoring board (DSMB) membership
- Aplagon
- Maze Therapeutics
- Vera Therapeutics
- Quris AI
Equity (Stock or stock options valued at greater than 5% ownership of a publicly traded company or equity of any value in a privately held company)
- Kuleana Technology, Inc
Founder/Co-Founder/Partner
- Kuleana Technology, Inc
Mount Sinai’s faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.